Voyager Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $53.6M | $189.6M | $36.6M |
| FY2017 | $50.4M | $184.5M | $31.5M |
| FY2018 | $130.6M | $177.0M | $46.9M |
| FY2019 | $255.2M | $354.8M | $86.0M |
| FY2020 | $107.3M | $261.6M | $104.4M |
| FY2021 | $98.8M | $193.9M | $117.4M |
| FY2022 | $100.3M | $159.4M | $99.0M |
| FY2023 | $115.0M | $351.3M | $68.8M |
| FY2024 | $93.3M | $393.1M | $71.4M |
| FY2025 | $56.2M | $252.3M | $65.3M |